Current Edition

QuickSTAT Announces Global Expansion Plan To Enhance Its Global Network and Cold Chain Logistics Capabilities for Life Sciences

Investment Supports Company’s Ongoing Focus on Logistics and Clinical Trial Supply Chain Integrity
QuickSTAT is making significant investments in its network and logistics capabilities to meet the evolving world of modern cold chain and the complex requirements of the industry.
The expansion will support QuickSTAT’s ongoing focus on logistics and transportation, and includes opening new Control Towers, an enhancement of existing facilities, and increased Customer Service support for its life science clients.  Temperature-controlled vehicles have been added to its fleet, providing additional Priority Ground Logistics Solutions.
Transportation experts specializing in Drug Development logistics and Cold Chain from around the world have joined the QuickSTAT team, providing consultation on stringent regulatory compliance, specialized packaging, DG transport, as well as best solutions to reach the most remote clinical sites and emerging market areas.
As part of the the expansion, a Control Tower in France has been opened to support clients in the region, and the UK Control Tower has been expanded, both designed for GDP Quality. They will provide 24/7 transportation and logistics services, as well as in-transit storage for patient-clinical specimens, API, vaccines and investigational drugs, utilizing GDP principles and best practices. Investments in LATAM, APAC and Africa are under way.
 “Our investment in an increased global footprint, the recruitment of top industry specialists, along with our market-leading IT platform that helps clients manage their clinical trials demonstrates our commitment to the Life Science community.  We are very excited about the enhanced solutions and tools we can provide ” says Dominique Brown, COO, QuickSTAT.
Contact:         Adrian Lee-Mohan
Tel: +44 (0) 8757 7590